Decision on Stock Split and Share Count Correction
- Decision on 5:1 reverse stock split (par value from KRW 100 to KRW 500)
- Total shares after split: 5,577,410 (corrected from 5,575,074)
- 2,336 fractional shares to be merged into treasury
- Purpose: stabilize stock price and enhance corporate value through appropriate share count
- Schedule: shareholder meeting 2026-03-31, effective 2026-04-16, trading suspension 2026-04-14~05-14, listing 2026-05-15
- No capital reduction; subject to shareholder approval
ADVERTISEMENT (250px+)
KOSDAQ Filing Information
- Filing: [Correction of Description] Decision on Stock Consolidation
- Company: KMPHARMACEUTICAL (225430)
- Submission: KMPHARMACEUTICAL Co.,Ltd.
- Receipt: 05-07-2026
- Under KRX KOSDAQ Market Division